# Unicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
Canonical URL: https://biopharmsignal.com/news/UNCY/unicycive-therapeutics-announces-first-quarter-2026-financial-results-and-provides-business-update
Ticker: UNCY
Company: Unicycive Therapeutics
Source: Unicycive Therapeutics
Published: 2026-05-12 11:05 EST
Original Source URL: https://ir.unicycive.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-06-30 11:05 EST — [Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA)](https://biopharmsignal.com/news/UNCY/unicycive-therapeutics-receives-complete-response-letter-from-fda-regarding-resu-2c152ab0) — Source: Unicycive Therapeutics
- 2026-05-12 11:05 EST — [Unicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update](https://biopharmsignal.com/news/UNCY/unicycive-therapeutics-announces-first-quarter-2026-financial-results-and-provides-business-update) — Source: Unicycive Therapeutics
- 2026-04-09 11:05 EST — [Unicycive Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference](https://biopharmsignal.com/news/UNCY/unicycive-therapeutics-to-present-at-the-25th-annual-needham-virtual-healthcare-conference) — Source: Unicycive Therapeutics
- 2026-03-30 11:05 EST — [Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update](https://biopharmsignal.com/news/UNCY/unicycive-therapeutics-announces-full-year-2025-financial-results-and-provides-business-update) — Source: Unicycive Therapeutics
- 2026-02-04 12:05 EST — [Unicycive Therapeutics to Participate in a Fireside Chat at Guggenheim’s Emerging Outlook: Biotech Summit](https://biopharmsignal.com/news/UNCY/unicycive-therapeutics-to-participate-in-a-fireside-chat-at-guggenheim-s-emerging-outlook-biotech-summit) — Source: Unicycive Therapeutics
## Related News
- 2026-07-21 20:15 EST — BFRG — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8)
- 2026-07-21 20:05 EST — CLPT — [ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-second-quarter-2026-results-august-3-2026-6e4f3c05)
- 2026-07-21 20:05 EST — TCMD — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004)
- 2026-07-21 20:05 EST — PIII — [P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/PIII/p3-health-partners-schedules-second-quarter-2026-earnings-release-and-conference-6c9bd8a7)
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)